The long term goal of this proposal is to be able to isolate genes influencing behavioral and physiological traits elicited by methamphetamine exposure. Quantitative trait locus (QTL) mapping studies in a B6D2F2 population will be performed using PCR of SSLPs with MIT microsatellite markers for traits (thermal responses, exophthalmus, stereotyped behavior and changes in home cage activity) preliminarily mapped in a 25 strain BXD RI study. A QTL is a chromosome site containing a gene or genes which appear to influence these responses to the psychostimulant, methamphetamine. Novel information about the heritability of these traits and the location of the responsible genes will be determined. Due to mouse human genomic synteny, the mapping data should be directly applicable to human research. The proposed mRNA differential display analysis of amphetamine-regulated expression in brain will address the hypothesis that the basis of many drug abuse trait related QTLs are at the expression level. As an aside to the genetic aspect of the experiment, the cloning of genes differentially regulated (through either environmental or genetic mechanisms) by acute and chronic administration of meth-amphetamine will likely yield valuable results relevant at the basic scientific level and possibly clinically as well. Insights into the neural molecular mechanisms that underlie acute and chronic amphetamine action may be gained.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DA005925-01
Application #
2861931
Study Section
Special Emphasis Panel (ZDA1-MXS-M (12))
Program Officer
Babecki, Beth
Project Start
1999-06-01
Project End
Budget Start
1999-06-01
Budget End
2000-05-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239